Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the interest coverage ratio high or low?
The interest coverage ratio of 0.89x is 87% below its 5-year average of 6.73x, near the low end of its 5-year range (0.50x–9.41x).
As of the fiscal period ended Tuesday, June 30, 2026. 83.10% below its 12-month average of 5.24x.
Reported quarterly interest coverage; no daily interpolation.
INTEREST COVERAGE RATIO
0.89x
INTEREST COVERAGE RATIO AVG TTM
5.24x
INTEREST COVERAGE RATIO AVG 3Y
6.69x
INTEREST COVERAGE RATIO AVG 5Y
6.73x
INTEREST COVERAGE RATIO AVG 10Y
N/A
INTEREST COVERAGE RATIO AVG 15Y
N/A
INTEREST COVERAGE RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
-83.10%
CURRENT VS 3Y AVG
-86.77%
CURRENT VS 5Y AVG
-86.83%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
6.96x
median of 80 covered companies
CURRENT VS SECTOR MEDIAN
-87.27%
vs the sector median at left
Market Cap
$34.57B
Interest Coverage Ratio
65.20x
TTM Avg
99.43x
3Y Avg
62.91x
5Y Avg
55.69x
Market Cap
$34.08B
Interest Coverage Ratio
49.83x
TTM Avg
40.70x
3Y Avg
32.97x
5Y Avg
24.93x
Market Cap
$32.36B
Interest Coverage Ratio
6.14x
TTM Avg
5.67x
3Y Avg
11.29x
5Y Avg
26.04x
Market Cap
$32.10B
Interest Coverage Ratio
14.80x
TTM Avg
14.41x
3Y Avg
13.27x
5Y Avg
12.34x
Market Cap
$32.10B
Interest Coverage Ratio
7.63x
TTM Avg
8.79x
3Y Avg
9.45x
5Y Avg
11.57x
Market Cap
$31.78B
Interest Coverage Ratio
-11.24x
TTM Avg
4.28x
3Y Avg
3.30x
5Y Avg
3.63x
Market Cap
$31.42B
Interest Coverage Ratio
1.99x
TTM Avg
1.99x
3Y Avg
1.99x
5Y Avg
1.99x
Market Cap
$30.89B
Interest Coverage Ratio
12.84x
TTM Avg
11.03x
3Y Avg
12.05x
5Y Avg
13.28x
| NAME | MARKET CAP | INTEREST COVERAGE RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Alcon Inc. (ALC) | $34.82B | 0.89x | 5.24x | 6.69x | 6.73x |
| ResMed Inc. (RMD)vs › | $34.57B | 65.20x | 99.43x | 62.91x | 55.69x |
| DexCom, Inc. (DXCM)vs › | $34.08B | 49.83x | 40.70x | 32.97x | 24.93x |
| GE HealthCare Technologies Inc. (GEHC)vs › | $32.36B | 6.14x | 5.67x | 11.29x | 26.04x |
| Zoetis Inc. (ZTS)vs › | $32.10B | 14.80x | 14.41x | 13.27x | 12.34x |
| Biogen Inc. (BIIB)vs › | $32.10B | 7.63x | 8.79x | 9.45x | 11.57x |
| Centene Corp. (CNC)vs › | $31.78B | -11.24x | 4.28x | 3.30x | 3.63x |
| Alnylam Pharmaceuticals, Inc. (ALNY)vs › | $31.42B | 1.99x | 1.99x | 1.99x | 1.99x |
| Waters Corporation (WAT)vs › | $30.89B | 12.84x | 11.03x | 12.05x | 13.28x |
| Medline Inc. (MDLN)vs › | $29.75B | 2.72x | 2.21x | 1.60x | 1.60x |
Interest Coverage
0.9x
Debt/Equity
0.25
Current Ratio
2.09
Formula: Interest Coverage = EBIT / Interest Expense
Reference ranges:
Note: Interest coverage should be compared with historical interest expense, operating income, and industry capital structure.
Interest Coverage = EBIT / Interest Expense
The interest coverage ratio measures operating earnings relative to interest expense.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | INTEREST COVERAGE RATIO |
|---|---|
| 2026-06-30 | 0.89x |
| 2026-03-31 | 8.06x |
| 2025-12-31 | 5.91x |
| 2025-09-30 | 6.51x |
| 2025-06-30 | 4.84x |
| 2025-03-31 | 9.41x |
| 2024-12-31 | 8.23x |
| 2024-09-30 | 6.78x |
| 2024-06-30 | 6.36x |
| 2024-03-31 | 8.18x |
| 2023-12-31 | 4.20x |
| 2023-09-30 | 6.23x |
| 2023-06-30 | 5.63x |
| 2023-03-31 | 5.70x |
| 2022-12-31 | 0.50x |
| 2022-09-30 | 6.03x |
| 2022-06-30 | 6.45x |
| 2022-03-31 | 8.48x |
| 2021-12-31 | 6.43x |
| 2021-09-30 | 0.65x |
| 2021-06-30 | 7.63x |
| 2021-03-31 | 4.81x |
| 2020-12-31 | 4.45x |
| 2020-09-30 | -4.03x |
| 2020-06-30 | -15.53x |
| 2020-03-31 | -0.90x |
| 2019-12-31 | -2.00x |
| 2019-09-30 | -0.51x |
| 2019-06-30 | -1.51x |
| 2019-03-31 | -5.33x |
| 2018-12-31 | -25.00x |
| 2018-09-30 | -40.57x |
| 2018-06-30 | 6.33x |
| 2018-03-31 | 9.33x |
| 2017-12-31 | -11.40x |
